C17:0 GB3
| Catalog Number | BL-M001155 |
| CAS Number | 536745-81-0 |
| Description | C17:0 GB3, a synthetic glycosphingolipid, serves as a valuable tool in investigating lysosomal storage disorders, particularly Fabry disease. Its application extends to the advancement of therapeutic interventions for addressing these pathological conditions. |
 | |
| IUPAC Name | N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]heptadecanamide |
| Synonyms | C17:0 Globotriaosylceramide; N-Heptadecanoyl ceramide trihexoside; C17 Ceramide Trihexoside (d18:1/17:0) |
| Molecular Weight | 1038.36 |
| Molecular Formula | C53H99NO18 |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 61.31%, H 9.61%, O 27.73% |
| Canonical SMILES | CCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)OC3C(C(C(C(O3)CO)O)O)O)O)O)O)O)C(C=CCCCCCCCCCCCCC)O |
| InChI | InChI=1S/C53H99NO18/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-41(59)54-36(37(58)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)35-67-51-47(65)44(62)49(39(33-56)69-51)72-53-48(66)45(63)50(40(34-57)70-53)71-52-46(64)43(61)42(60)38(32-55)68-52/h28,30,36-40,42-53,55-58,60-66H,3-27,29,31-35H2,1-2H3,(H,54,59)/b30-28+/t36-,37+,38+,39+,40+,42-,43-,44+,45+,46+,47+,48+,49+,50-,51+,52+,53-/m0/s1 |
| InChI Key | FMSNZTFVKHTNKM-CNGLGKGFSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
